You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR DECA-DURABOLIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DECA-DURABOLIN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03545347 ↗ Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture. Completed Morten Tange Kristensen PT, PhD Phase 2 2018-09-03 This pilot trial investigates the preliminary effect and safety of a 12 week multi-modal intervention initiated during admission in the acute ward after hip fracture surgery. The intervention under investigation is a combination therapy consisting of physiotherapy, protein-rich nutritional supplement and nandrolone decanoate (Deca-Durabolin) supplement. The investigators expect the combination therapy to be a preliminary effective and safe treatment in elderly patients with hip fracture and that this combination therapy intervention program is more efficacious in improving muscle strength, and physical function 14 weeks after hip fracture surgery, compared to physiotherapy, protein-rich nutritional supplement plus placebo.
NCT03588767 ↗ Endocrine Response of the Organism to Polytrauma Recruiting University Hospital Ostrava N/A 2017-06-01 The serious injury causes a complex acute response of the organism to the injury in affected patients, which is manifested in the neuroendocrine, immune and metabolic areas, with an often persisting catabolic state, with a subsequent negative impact upon bone metabolism. By a timely administration of the D3 vitamin and an anabolic, we attempt to achieve an earlier activation of the anabolic phase of patient resuscitation after serious trauma regarding the monitoring of laboratory values of bone metabolism.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DECA-DURABOLIN

Condition Name

Condition Name for DECA-DURABOLIN
Intervention Trials
Hip Fractures 1
Polytrauma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DECA-DURABOLIN
Intervention Trials
Multiple Trauma 1
Hip Fractures 1
Fractures, Bone 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DECA-DURABOLIN

Trials by Country

Trials by Country for DECA-DURABOLIN
Location Trials
Denmark 1
Czechia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DECA-DURABOLIN

Clinical Trial Phase

Clinical Trial Phase for DECA-DURABOLIN
Clinical Trial Phase Trials
Phase 2 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DECA-DURABOLIN
Clinical Trial Phase Trials
Completed 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DECA-DURABOLIN

Sponsor Name

Sponsor Name for DECA-DURABOLIN
Sponsor Trials
Morten Tange Kristensen PT, PhD 1
University Hospital Ostrava 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DECA-DURABOLIN
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.